Abstract:Abstract Background Keloids are an extreme form of abnormal scarring that result from a pathological fibroproliferative wound healing process. The molecular mechanisms driving keloid pathology remain incompletely understood, hindering development of targeted, effective therapies. Recent studies in our laboratory demonstrated that keloid keratinocytes exhibit adhesion abnormalities and display a transcriptional signature reminiscent of cells undergoing epithelial-mesenchymal transition (EMT), suggesting a role for EMT in keloid pathology. In the current study, we further define the EMT-like phenotype of keloid scars and investigate regulation of EMT-related genes in keloid. Methods Primary keratinocytes from keloid scar and normal skin were cultured in the presence or absence of transforming growth factor beta 1 (TGF-β1) +/− inhibitors of TGF-β1 and downstream signaling pathways. Gene expression was measured using quantitative polymerase chain reaction. Migration was analyzed using an in vitro wound healing assay. Proteins in keloid scar and normal skin sections were localized by immunohistochemistry. Statistical analyses utilized SigmaPlot (SyStat Software, San Jose, CA) or SAS® (SAS Institute, Cary, NC). Results In keloid and normal keratinocytes, TGF-β1 regulated expression of EMT-related genes, including hyaluronan synthase 2, vimentin, cadherin-11, wingless-type MMTV integration site family, member 5A, frizzled 7, ADAM metallopeptidase domain 19, and interleukin-6. Inhibition of canonical TGF-β1 signaling in keloid keratinocytes significantly inhibited expression of these genes, and TGF-β1 stimulation of normal keratinocytes increased their expression. The inhibition of the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway or the p38 mitogen-activated protein kinase pathway attenuated TGF-β1-induced expression of subsets of these genes. Migration of keloid keratinocytes, previously shown to be increased compared with normal keratinocytes, was significantly reduced by inhibition of TGF-β1 or ERK1/2 signaling. Biomarkers of EMT, including reduced E-cadherin and increased active β-catenin, were observed in keloid epidermis in vivo. However, evidence of basement membrane breakdown in keloid scar was not observed. Conclusions The results suggest that keloid keratinocytes exist in an EMT-like metastable state, similar to activated keratinocytes in healing wounds. The EMT-like gene expression pattern of keloid keratinocytes is regulated by canonical and non-canonical TGF-β1 signaling pathways. Therefore, interventions targeting TGF-β1-regulated EMT-like gene expression in keloid keratinocytes may serve to suppress keloid scarring.

A Study of the Abnormalities of Human Epiderm in Keloids and Hypertrophic Scars

[The Expression of Tenascin-C Mrna in Keloids and Hypertrophic Scars].

[Study on the Expression of Tenascin-C in Keloid and Hyperplastic Scar].

Mapping Variation of Extracellular Matrix in Human Keloid Scar by Label-Free Multiphoton Imaging and Machine Learning.

The differences and identities in genes of keloid and hypertrophic scar

Studies of Transforming Growth Factors Beta 1-3 and Their Receptors I and II in Fibroblast of Keloids and Hypertrophic Scars.

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Genome-wide Analysis of Dysregulated RNA-binding Proteins and Alternative Splicing Genes in Keloid

Detection and Analysis of Long Noncoding RNA Expression Profiles Related to Epithelial-Mesenchymal Transition in Keloids

Immunogenetic Regulation of HLA-DR, DQ, DP and CD1a Positive Cells in the Pathogenesis of Keloid and Hypertrophic Scar

Nestin expression in keloid and hypertrophic scarring

Immunogenetic regulation of HLA- Ⅱ type and CD1a positive cells in peripheral blood of patients with abnormal scar

[Expression of Thymosin Beta 4 Mrna Expression in Keloid Tissues and Fibroblasts Cultured from Keloid and Its Significance].

Difference in the expression of associated gene-cluster between proliferative and mature stage hypertrophic scars

Differential Gene Expression Profile of Keloids: a Study with Cdna Microarray

Association between MeCP2 and Smad7 in the pathogenesis and development of pathological scars

The Expression and Significance of Secreted Protein,Acidic and Rich in Cysteine in Hypertrophic Scar and Keloid Tissue

Alterations in epidermal stem cells within the pilosebaceous unit in atrophic acne scars

Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1

Comparative Study of Microrna Profiling in Keloid Fibroblast and Annotation of Differential Expressed Micrornas.

[Literature Mining and Bioinformatic Analysis of Dysregulated Genes in Hypertrophic Scar].